General Catalyst-backed healthtech startup Vial laid off employees

México Noticias Noticias

General Catalyst-backed healthtech startup Vial laid off employees
México Últimas Noticias,México Titulares
  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 51%

Buzzy healthtech startup Vial slashed an entire division weeks before a $67 million raise from General Catalyst. Insiders say they had no idea the layoffs were coming.

Vial CRO and co-founder Andrew Brackin started the company in 2020 after stints at startup Growth and insurance brokerage Newfront. He was also a fellow at the Thiel Foundation in 2013.Vial let go of its entire site network division, 40 to 50 people, last October, Insider has learned.Just a month after the October cuts, the healthtech startup announced a $67 million funding round.

The Fall job cuts were preceded by another round of layoffs in Summer 2022 that affected multiple employees working on regulatory issues, said one former employee. Representatives for Vial did not respond to multiple requests for comment. General Catalyst also did not respond to request for comment.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

BusinessInsider /  🏆 729. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Amazon enabling more sellers to use its Prime infrastructureAmazon enabling more sellers to use its Prime infrastructureAmazon is turning into a logistics as a service provider, allowing merchants to use its Prime logistics without actually needing to sell on Amazon.
Leer más »

Why the stock market isn't impressed with the first monthly decline in inflation in more than 2 yearsWhy the stock market isn't impressed with the first monthly decline in inflation in more than 2 yearsWhy the stock market isn’t impressed with the first monthly decline in inflation in more than 2 years
Leer más »

Why the stock market isn't impressed with the first monthly decline in consumer prices in more than 2 yearsWhy the stock market isn't impressed with the first monthly decline in consumer prices in more than 2 yearsInflation data may no longer be the big catalyst for stocks that it once was.
Leer más »

Novartis CEO Vas Narasimhan on future of gene therapy and ZolgensmaNovartis' CEO said gene therapy is a 'nuanced puzzle' everyone is trying to figure out, but he's still committed to the cutting-edge treatments
Leer más »

How Biden plans to keep student debt from growing after graduationHow Biden plans to keep student-loan borrowers' debt from piling up after they graduate — and crack down on the colleges that make that happen
Leer más »

Goldman Sachs reviews private jet spending amid layoffsGoldman Sachs is reviewing spending on its private jets, which CEO David Solomon has used for lavish getaways
Leer más »



Render Time: 2025-02-27 16:56:19